CD34 cell therapy (Applied Immune Sciences/RPR Gencell)

N/A

Report date: 2023/02/17 21:03:03

Base Information

Drug NameCD34 cell therapy (Applied Immune Sciences/RPR Gencell)
Drug Alias NameCD34 cell therapy
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionAnti-CD34Cell replacements
TargetsHematopoietic progenitor cell antigen CD34
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesApplied Immune Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApplied Immune SciencesRpr Gencell
Active IndicationsN/A
Inactive IndicationsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A